NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018

  • Shah M
  • Goldner W
  • Halfdanarson T
  • et al.
N/ACitations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.

Cite

CITATION STYLE

APA

Shah, M. H., Goldner, W. S., Halfdanarson, T. R., Bergsland, E., Berlin, J. D., Halperin, D., … Zuccarino-Catania, G. (2018). NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. Journal of the National Comprehensive Cancer Network, 16(6), 693–702. https://doi.org/10.6004/jnccn.2018.0056

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free